WCN26-2323 GUT MICROBOTA OF HEMODIALYSIS PATIENTS PRODUCCES HIGH LEVELS OF TRIMETHYLAMINE N-OXIDE, A RISK FACTERS FOR CARDIOVASCULAR COMPLICATIONS

Read full text Summarise with VIRAT
Authors: Hanae Wakabayashi, Masayoshi Ishii, Hiroko Inoue, Takayuki Fujii, Sumihiko Sato, Masashi Aizawa, Katsuhiko Asanuma
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The gut microbiota in patients with chronic kidney disease is characterized by dysbiosis. Since gut dysbiosis can affect kidney function and lead to various diseases, it is important to elucidate the characteristics of gut microbiota in patients with chronic kidney disease. Trimethylamine N-oxide (TMAO), a uremic toxin produced by the gut microbiota, promotes arteriosclerosis and increases the risk of cardiovascular complications. We conducted this study to clarify whether the gut microbiota of hemodialysis patients changes from healthy individuals, resulting in increased TMAO production.

Fields of Study & Subjects

Gut microbiota and health Dialysis and Renal Disease Management Oral microbiology and periodontitis research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104974–104974
Publication date
25 March 2026
Language
EN